Evaluation of Vaccine Hesitancy, Anti-Vaccination, and Anxiety Levels for Medical Secretaries During COVID-19 Pandemic

ABSTRACT

On December 31, 2019, after reporting the existence of pneumonia cases of unknown cause in Wuhan city of Hubei province of China, the World Health Organization (WHO) announced that the virus causing the disease is a member of the coronavirus family. Study Protocol and Ethics Committee Approval This Study involving human participants was in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. In order to select a sample that can represent this universe, When Type I error amount (alpha) was chosen as 0.05, test power (1-beta) as 0.8, effect size as 0.23, and alternative hypothesis (H1) as two-tailed. the minimum number of participants required to find a significant difference was calculated as 149. The questions querying the sociodemographic characteristics of the Study can be briefly defined as follows variables such as age, gender, marital status, number of children, education level, smoking, working unit (service, intensive care, emergency unit, operating room, polyclinics), presence of chronic disease (diabetes mellitus, hypertension, asthma, COPD, cardiovascular disease), statuses of working in COVID-19 clinics during pandemic process, being infected with COVID-19 disease, being vaccinated against COVID-19, presence of hesitation about general vaccination programs, presence of hesitation about the COVID-19 vaccine, the status of believing in the protection of the COVID-19 vaccine, ideas on making the COVID19 vaccine legally mandatory, status of catching COVID-19 disease, if COVID-19 was caught after vaccination, after which vaccine and after which dose and situations that worry the person during COVID-19 process